Radioimmunotherapy and Temozolomide in the Treatment of Glioblastoma Multiforme: A 20 Year Experience

Journal article

L. Li, T.S. Quang, E.J. Gracely, J.G. Emrich, J. Kim, T.E. Yaeger, J.M. Jenrette, S.C. Cohen and L.W. Brady

International journal of radiation oncology, biology, physics, v 69(3), pp S48-S48

01 Nov 2007

Additional Links

6 Record Views

Title: Radioimmunotherapy and Temozolomide in the Treatment of Glioblastoma Multiforme: A 20 Year Experience
Creators: L. Li - Drexel University
T.S. Quang - University of California Davis Medical Center
E.J. Gracely - Drexel University
J.G. Emrich - Drexel University
J. Kim - Drexel University
T.E. Yaeger - Wake Forest University
J.M. Jenrette - Medical University of South Carolina
S.C. Cohen - Bryn Mawr Hospital
L.W. Brady - Drexel University
Publication Details: International journal of radiation oncology, biology, physics, v 69(3), pp S48-S48
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: MD (Doctor of Medicine) Program; Radiation Oncology (and Nuclear Medicine); [Retired Faculty]; Physical Therapy (and Rehabilitation Sciences)
Web of Science ID: WOS:000249950200086
Other Identifier: 991019169305604721

This publication has contributed to the advancement of the following goals:

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Domestic collaboration
Web of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging